6929 Stock Overview
An investment holding company, researches, develops, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 6929 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
OrbusNeich Medical Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.83 |
| 52 Week High | HK$16.86 |
| 52 Week Low | HK$3.79 |
| Beta | 0 |
| 1 Month Change | -23.40% |
| 3 Month Change | -33.28% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -70.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6929 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -24.5% | -3.8% | -2.2% |
| 1Y | n/a | -28.7% | 18.3% |
Return vs Industry: Insufficient data to determine how 6929 performed against the Hong Kong Medical Equipment industry.
Return vs Market: Insufficient data to determine how 6929 performed against the Hong Kong Market.
Price Volatility
| 6929 volatility | |
|---|---|
| 6929 Average Weekly Movement | 7.3% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.7% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 6929's share price has been volatile over the past 3 months.
Volatility Over Time: 6929's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 954 | David Chien | orbusneich.com |
OrbusNeich Medical Group Holdings Limited, an investment holding company, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures.
OrbusNeich Medical Group Holdings Limited Fundamentals Summary
| 6929 fundamental statistics | |
|---|---|
| Market cap | HK$3.17b |
| Earnings (TTM) | HK$278.81m |
| Revenue (TTM) | HK$1.17b |
10.6x
P/E Ratio2.5x
P/S RatioIs 6929 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6929 income statement (TTM) | |
|---|---|
| Revenue | US$149.38m |
| Cost of Revenue | US$46.37m |
| Gross Profit | US$103.01m |
| Other Expenses | US$67.38m |
| Earnings | US$35.64m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Mar 07, 2024
| Earnings per share (EPS) | 0.043 |
| Gross Margin | 68.96% |
| Net Profit Margin | 23.86% |
| Debt/Equity Ratio | 0% |
How did 6929 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/05 08:12 |
| End of Day Share Price | 2024/03/05 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
OrbusNeich Medical Group Holdings Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shun Kei Law | CCB International Securities Limited |
| Zhishun Siu | CCB International Securities Limited |
| null null | China International Capital Corporation Limited |